1. Home
  2. CRDL vs FIRY Comparison

CRDL vs FIRY Comparison

Compare CRDL & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.18

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Logo Firy Inc. Class A Common Stock

FIRY

Firy Inc. Class A Common Stock

N/A

Current Price

$11.97

Market Cap

127.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CRDL
FIRY
Founded
2017
N/A
Country
Canada
United States
Employees
N/A
370
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
132.6M
127.2M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CRDL
FIRY
Price
$1.18
$11.97
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
806.5K
86.4K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$7.92
52 Week High
$1.71
$10.74

Technical Indicators

Market Signals
Indicator
CRDL
FIRY
Relative Strength Index (RSI) 53.46 67.99
Support Level $0.95 $7.97
Resistance Level $1.38 N/A
Average True Range (ATR) 0.10 0.67
MACD 0.01 0.24
Stochastic Oscillator 60.13 64.19

Price Performance

Historical Comparison
CRDL
FIRY

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About FIRY Firy Inc. Class A Common Stock

Firy Inc, formerly Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. Its reportable segments are: the Skillz segment and the RZR segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is a performance marketing platform that enables advertisers to acquire, retain, and monetize users across mobile, connected television (CTV), and other digital channels. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube, among others. It generates the majority of its revenue from the Skillz segment. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: